Overall, our findings show that BOP1 expression is linked to the tumor microenvironment, immune cell infiltration, MSI, and TMB; impacts patient prognosis; and gives new insights into immunotherapy and immunosuppressive drug development. Here, BOP1 is linked to neoplasm.